News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Using Iron to Destroy Multiple Myeloma Cancer Cells
September 22, 2025 - Grantee/Partner News
- Illuminating Druggable Genome (IDG)
A Decade-Long Program Investigating Understudied Proteins Builds a Foundation for the Future
July 21, 2025 - NCATS News
- Illuminating Druggable Genome (IDG)
- Our Impact on Drug Discovery and Development
Since 2013, the Illuminating the Druggable Genome program has helped researchers learn about understudied protein families to find potential therapeutics.
Read ArticleProteins Important in Neural Communication Have Different Roles Than Previously Thought
July 1, 2025 - Grantee/Partner News
- Illuminating Druggable Genome (IDG)
N.C. A&T Distinguished Professor’s Biomedical Research Garners Collaboration, Support
May 7, 2025 - Grantee/Partner News
- Illuminating Druggable Genome (IDG)
Doggedness and Heart: UGA Cancer Center Tackles Cancer’s Hardest Questions
February 20, 2024 - Grantee/Partner News
- Illuminating Druggable Genome (IDG)
NIH Funds Antibody Discovery for Difficult Protein Targets
October 6, 2023 - Media Coverage
- Illuminating Druggable Genome (IDG)
Target Watch Sheds Light on Overlooked Proteins
July 31, 2020 - NCATS News
- Illuminating Druggable Genome (IDG)
The Illuminating the Druggable Genome program, supported by the NIH Common Fund and administered through NCATS and the National Institute of Diabetes and Digestive and Kidney Diseases, has partnered with Nature Reviews Drug Discovery to create Target Watch, which highlights understudied protein targets.